Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials. | ClinicLens
Culture-based monitoring of bacterial load is slow and susceptible to missing data, contributing to the length and cost of TB clinical trials. Non-culture-based alternatives, like the Tuberculosis Molecular Load Bacterial Assay (TB-MBLA), could represent a solution. Our objective
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.